0000000000119919

AUTHOR

E Roz

showing 16 related works from this author

Occurrence of S100A7 in a large sample-set of breast cancer tissues

2010

S100A7 Proteomics
researchProduct

MULTIOMICS ANALYSIS OF S100 PROTEINS IN BREAST CANCER

2015

The S100 gene family is the largest subfamily of calcium binding proteins of EF-hand type, expressed in tissue and cell-specific manner. S100 proteins act as intracellular regulators and as extracellular signaling. Within cells, S100 have been involved in the regulation of proliferation, differentiation, apoptosis, energy metabolism, inflammation, migration and invasion via interactions with a variety of target proteins. Extracellular S100 proteins act in an autocrine and paracrine manner through the activation of surface receptors that regulate cell proliferation, differentiation, survival and migration. More recently, there is growing interest in the S100 proteins and their relationship w…

Settore BIO/06 - Anatomia Comparata E CitologiaS100 proteins
researchProduct

Clinicopathological correlations of MMP-2 and MMP-9 in breast cancer

2009

Breast cancer Invasion
researchProduct

Myc Promoter-Binding Protein-1 (MBP-1) transcriptionally represses ERBB2 gene, and identifies new subtypes of ERBB2 negative breast tumors

2011

Settore BIO/18 - GeneticaBreast CancerERBB2 geneMyc Promoter-Binding Protein-1 (MBP-1)
researchProduct

HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily.

2013

According to the ToGA trial, HER2 has been shown to be predictive for the success of treatment with trastuzumab in advanced gastric cancer (AGC). A number of studies have analyzed HER-2/neu overexpression in gastric carcinoma and identified the rate of HER2 positivity to be markedly varied. To date, the prevalence of HER2 overexpression in Sicilian people with AGC is unknown. Therefore, in the present study, a retrospective immunohistochemical analysis of HER2 was performed in a cohort of 304 AGC samples that were obtained from the archives of 10 Sicilian anatomopathological diagnostic units in order to verify the positive rate of HER2-positive cases. Furthermore, the characteristics of his…

OncologyCancer Researchmedicine.medical_specialtyPathologymedicine.medical_treatmentGastric adenocarcinoma; HER2 status; Sicily; TrastuzumabHER2 gastric carcinomaSettore MED/08 - Anatomia PatologicaTrastuzumabInternal medicinemedicineStage (cooking)skin and connective tissue diseasesneoplasmsSicilyChemotherapyHER2 status; Sicily; gastric adenocarcinoma; trastuzumabHER2 statusbusiness.industryCancerArticlesmedicine.diseaseMolecular medicinetrastuzumabOncologyCohortTubular AdenocarcinomaImmunohistochemistrygastric adenocarcinomabusinessmedicine.drug
researchProduct

Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas in Sicily: A multicentre retrospective study in relation …

2012

Little information from clinical trials is available regarding the efficacy of trastuzumab treatment in subcentimetric breast carcinomas (BCs). The aim of this study was to verify the existence of correlations between HER2 and hormone receptor status, Ki67 values, grade, histotype and node involvement in a cohort of pT1a,b BCs from an area not widely covered by screening campaigns. A total of 410 pT1a,b BC formalin-fixed paraffin-embedded samples collected from eight Sicilian Anatomo-Pathological Units (APUs) were classified according to the WHO classification and tumour grading was established. Estrogen and progesterone receptor status, Ki67 labelling index and HER2 status were available. …

OncologyGynecologyCancer Researchmedicine.medical_specialtybusiness.industryCancerRetrospective cohort studyArticlesProgesterone Receptor StatusSettore MED/08 - Anatomia Patologicamedicine.diseaseClinical trialBreast carcinoma immunohistochemistry HER2medicine.anatomical_structureOncologyTrastuzumabInternal medicineCohortsmall size breast cancer screening campaign staging immunohistochemistrymedicineBreast carcinomabusinessLymph nodemedicine.drug
researchProduct

Identification of a prognostic gene signature associated with MBP-1 expression in ErbB2-negative breast carcinomas

2014

The ENO1 transcript, which encodes the glycolitic enzyme alpha-enolase, can be translated into a shorter nuclear protein called Myc-promoter Binding Protein-1 (MBP-1) by using an alternative translation start site. MBP-1 acts as a negative regulator of c-Myc, ErbB2 and Cox2 genes (1). Several evidences indicate that MBP-1 acts as a tumor suppressor in breast carcinoma and prostate cancer and its expression results in a reduced invasive ability (2). In our previous studies, we showed that MBP-1 is expressed and easily detectable in normal breast epithelial cells, but a loss of expression occurs in most primary invasive ductal carcinomas (IDC) of the breast. Furthermore, in these tumors MBP-1…

Settore BIO/18 - GeneticaMBP-1 Breast cancer mRNA expression profiles
researchProduct

S100S PROTEIN EXPRESSION IN A LARGE SAMPLE-SET OF BREAST CANCER TISSUES

2010

S100 proteins are low molecular weight proteins ranging in size from 9 to 13 kDa. They form homo- and heterodimers and even oligomers and are expressed in tissue and cell-specific manner [1]. It is well documented, infact, that S100 proteins have a broad range of intracellular and extracellular functions. Intracellular functions include regulation of protein phosphorylation, enzyme activity, calcium homeostasis, regulation of cytoskeletal components and regulation of transcriptional factors, so they are involved in several biological processes including cell cycle regulation, cell growth, cell differentiation, and motility [2]. Extracellularly they act in a cytokine like manner through the …

S100 proteomics
researchProduct

MMP-2, MMP-9 and MMP-14 in breast cancer: clinicopathological correlations.

2009

MMP2 MMP9 MMP14 MMPs Breast cancerSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct

Morphological and biomolecular charachteristics of subcentimetric invasive breast carcinomas: a sicilian multicentric retrospective analysis

2010

breast carcinoma her-2 stageSettore MED/08 - Anatomia Patologica
researchProduct

Large-scale proteomic identification of S100 proteins in breast cancer tissues

2010

Abstract Background Attempts to reduce morbidity and mortality in breast cancer is based on efforts to identify novel biomarkers to support prognosis and therapeutic choices. The present study has focussed on S100 proteins as a potentially promising group of markers in cancer development and progression. One reason of interest in this family of proteins is because the majority of the S100 genes are clustered on a region of human chromosome 1q21 that is prone to genomic rearrangements. Moreover, there is increasing evidence that S100 proteins are often up-regulated in many cancers, including breast, and this is frequently associated with tumour progression. Methods Samples of breast cancer t…

Cancer ResearchProteomeBlotting WesternBreast NeoplasmsBioinformaticsS100 proteinlcsh:RC254-282Cohort StudiesBreast cancerSurgical oncologyBiomarkers TumorGeneticsmedicineHumansElectrophoresis Gel Two-DimensionalBreastNeoplasm MetastasisSettore BIO/06 - Anatomia Comparata E CitologiaGeneproteomicbusiness.industryS100 ProteinsChromosomePrognosismedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrimary tumorS100 proteinOncologybreast cancer tissuesSpectrometry Mass Matrix-Assisted Laser Desorption-IonizationProteomeFemaleStem cellbusinessResearch ArticleBMC Cancer
researchProduct

Nuclear Myc Promoter-Binding Protein-1 (MBP-1) Expression Is a Prognostic Factor in Invasive Ductal Breast Carcinoma

2010

Settore BIO/18 - GeneticaBreast cancerC-MYCMBP-1
researchProduct

Proteomic detection of S100 proteins in breastcancer tissues

2010

Breast cancer S100
researchProduct

AUTOANTIBODIES IDENTIFICATION IN BREAST CANCER SERA BY PROTEOMIC APPROACH

2011

autoantibodies
researchProduct

PROTEOMIC SIGNATURE OF HUMAN PRIMARY METASTATIC COLON CANCER AND ITS METASTASES TO LIVER

2014

colon cancer
researchProduct

Nuclear myc promoter-binding protein-1 (MBP-1) expression is a prognostic factor in invasive ductal breast carcinoma

2010

Insulators are DNA elements that block the extension of a condensed chromatin domain into a transcriptionally active region or prevent the interaction of a distal enhancer with a promoter when placed between the two. Human c-Myc and Pvt-1 genes map close each other and are separated by an intergenic region rich of DNAseI hypersensitivity sites. Starting from the observation that PVT1 expression is restricted to a low number of normal tissues compared to the wide distribution of c-Myc mRNA we focus our studies on the function and structure of the regions surrounding the DHs present between the two genes. Stable and transient transfection, indicate that one of the regions (HB-2.8) has enhance…

Settore BIO/18 - Geneticabreast cancerc-mycMBP-1
researchProduct